GLP-1R agonists consistently cause a reduction in muscle mass (usually measured as lean mass or fat-free mass) as part of their overall weight-loss effect
To learn more about us or to schedule a consultation, call us today at (470) 785-4616 or fill out our online appointment request form
Some research has shown potential benefits in models of Alzheimer's disease and other neurodegenerative conditions, though translating these findings to human cognitive symptoms remains uncertain
Both were targeted on the Spanish patients by using the clinical data from the SUSTAIN 2 trial, which included type 2 diabetes patients ( 18 years) inadequately controlled (HbA1c 7.0-10.5%) despite stable treatment with metformin, thiazolidinediones, or both, with female proportion of semaglutide population being 50%, mean age being 55.42 years, mean diabetes duration being 6.52 years, and mean HbA1c being 8.0% [5]
PlexusDx coordinates with your primary care physician and any specialists managing your diabetes to ensure medication changes are communicated clearly and tracked
EARLY ACCESS Be the first to book new treatments, services, and limited-time offers